Free Trial

CONMED (CNMD) News Today

CONMED logo
$59.92 -0.43 (-0.72%)
Closing price 03/27/2025 03:59 PM Eastern
Extended Trading
$59.34 -0.57 (-0.95%)
As of 03/27/2025 04:24 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
CONMED Co. stock logo
Bridge City Capital LLC Acquires 7,597 Shares of CONMED Co. (NYSE:CNMD)
Bridge City Capital LLC lifted its holdings in shares of CONMED Co. (NYSE:CNMD - Free Report) by 20.8% in the fourth quarter, according to its most recent filing with the SEC. The firm owned 44,056 shares of the company's stock after acquiring an additional 7,597 shares during the period. Bridge Ci
CONMED Co. stock logo
CONMED Co. (NYSE:CNMD) Shares Sold by Magnetar Financial LLC
Magnetar Financial LLC lowered its position in CONMED Co. (NYSE:CNMD - Free Report) by 100.0% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 3,067 shares of the company's stock after selling 34,496,933 shares during th
CONMED Co. stock logo
CONMED Co. (NYSE:CNMD) Shares Purchased by Natixis Advisors LLC
Natixis Advisors LLC boosted its position in CONMED Co. (NYSE:CNMD - Free Report) by 10.5% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 122,550 shares of the company's stock after purchasing an addit
CONMED Co. stock logo
Proficio Capital Partners LLC Invests $909,000 in CONMED Co. (NYSE:CNMD)
Proficio Capital Partners LLC bought a new stake in shares of CONMED Co. (NYSE:CNMD - Free Report) in the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund bought 13,277 shares of the company's stock, valued at approximately $909,000. A number of other hedge funds
CONMED Co. stock logo
266,625 Shares in CONMED Co. (NYSE:CNMD) Purchased by Raymond James Financial Inc.
Raymond James Financial Inc. acquired a new position in CONMED Co. (NYSE:CNMD - Free Report) in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor acquired 266,625 shares of the company's stock, valued at approximately $18,248,000. Raymond James
CONMED Co. stock logo
CONMED Co. (NYSE:CNMD) Shares Sold by Great Lakes Advisors LLC
Great Lakes Advisors LLC decreased its position in CONMED Co. (NYSE:CNMD - Free Report) by 6.3% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 105,399 shares of the company's stock after selling 7,034 s
CONMED Co. stock logo
Wealthfront Advisers LLC Makes New Investment in CONMED Co. (NYSE:CNMD)
Wealthfront Advisers LLC acquired a new position in shares of CONMED Co. (NYSE:CNMD - Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 84,593 shares of the company's stock, valued at approximately $5,790,00
CONMED Co. stock logo
CONMED Co. (NYSE:CNMD) Receives Consensus Rating of "Moderate Buy" from Brokerages
Shares of CONMED Co. (NYSE:CNMD - Get Free Report) have been assigned an average rating of "Moderate Buy" from the five ratings firms that are currently covering the firm, Marketbeat.com reports. Two investment analysts have rated the stock with a hold rating and three have assigned a buy rating t
CONMED Co. stock logo
Cooke & Bieler LP Has $45.45 Million Stock Holdings in CONMED Co. (NYSE:CNMD)
Cooke & Bieler LP reduced its stake in shares of CONMED Co. (NYSE:CNMD - Free Report) by 0.7% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 664,043 shares of the company's stock after selling 4,760 shares during the qu
CONMED Co. stock logo
Mutual of America Capital Management LLC Cuts Position in CONMED Co. (NYSE:CNMD)
Mutual of America Capital Management LLC cut its holdings in CONMED Co. (NYSE:CNMD - Free Report) by 85.0% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 4,680 shares of the company's stock after selling 26,533 shares d
CONMED Co. stock logo
Proficio Capital Partners LLC Makes New $909,000 Investment in CONMED Co. (NYSE:CNMD)
Proficio Capital Partners LLC purchased a new position in shares of CONMED Co. (NYSE:CNMD - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor purchased 13,277 shares of the com
RSI Alert: CONMED Now Oversold
CONMED Co. stock logo
CONMED (NYSE:CNMD) Hits New 52-Week Low - What's Next?
CONMED (NYSE:CNMD) Sets New 52-Week Low - Time to Sell?
CONMED Co. stock logo
Fisher Asset Management LLC Acquires 122,140 Shares of CONMED Co. (NYSE:CNMD)
Fisher Asset Management LLC lifted its holdings in shares of CONMED Co. (NYSE:CNMD - Free Report) by 41.4% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 417,430 shares of the company's stock after purchasing an a
CONMED Co. stock logo
CONMED (NYSE:CNMD) Reaches New 1-Year Low - Here's Why
CONMED (NYSE:CNMD) Sets New 1-Year Low - Here's Why
CONMED Co. stock logo
CONMED Co. Announces Quarterly Dividend of $0.20 (NYSE:CNMD)
CONMED Co. (NYSE:CNMD) declared a quarterly dividend on Tuesday, February 25th. Stockholders of record on Friday, March 14th will be given a dividend of 0.20 per share on Friday, April 4th. This represents a $0.80 dividend on an annualized basis and a dividend yield of 1.29%.
CONMED Corporation Announces Quarterly Cash Dividend
CONMED Co. stock logo
Olympiad Research LP Invests $340,000 in CONMED Co. (NYSE:CNMD)
Olympiad Research LP purchased a new position in shares of CONMED Co. (NYSE:CNMD - Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 4,972 shares of the company's stock, valued at approximately $340,000
CONMED Co. stock logo
CONMED (NYSE:CNMD) Hits New 1-Year Low - What's Next?
CONMED (NYSE:CNMD) Hits New 52-Week Low - What's Next?
CONMED Co. stock logo
Principal Financial Group Inc. Purchases 4,343 Shares of CONMED Co. (NYSE:CNMD)
Principal Financial Group Inc. lifted its position in CONMED Co. (NYSE:CNMD - Free Report) by 0.7% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 625,058 shares of the company's stock after purchasing an additional 4,343 s
CONMED Co. stock logo
CONMED Co. (NYSE:CNMD) Short Interest Up 9.4% in January
CONMED Co. (NYSE:CNMD - Get Free Report) was the recipient of a significant growth in short interest during the month of January. As of January 31st, there was short interest totalling 2,550,000 shares, a growth of 9.4% from the January 15th total of 2,330,000 shares. Based on an average daily volume of 431,000 shares, the short-interest ratio is currently 5.9 days.
CONMED Co. stock logo
CONMED Co. (NYSE:CNMD) Shares Acquired by Allspring Global Investments Holdings LLC
Allspring Global Investments Holdings LLC raised its position in shares of CONMED Co. (NYSE:CNMD - Free Report) by 44.5% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 223,142 shares of the company's stock after
CONMED Co. stock logo
CONMED Co. (NYSE:CNMD) Receives Average Recommendation of "Moderate Buy" from Brokerages
CONMED Co. (NYSE:CNMD - Get Free Report) has been given an average rating of "Moderate Buy" by the five brokerages that are currently covering the firm, Marketbeat reports. Two investment analysts have rated the stock with a hold rating and three have issued a buy rating on the company. The avera
CONMED Co. stock logo
CONMED Co. (NYSE:CNMD) Insider Richard Glaze Sells 257 Shares
CONMED Co. (NYSE:CNMD - Get Free Report) insider Richard Glaze sold 257 shares of CONMED stock in a transaction that occurred on Tuesday, February 11th. The shares were sold at an average price of $65.35, for a total transaction of $16,794.95. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink.
CONMED Co. stock logo
Legato Capital Management LLC Purchases 7,997 Shares of CONMED Co. (NYSE:CNMD)
Legato Capital Management LLC lifted its position in CONMED Co. (NYSE:CNMD - Free Report) by 41.2% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 27,400 shares of the company's stock after buying an add
CONMED Co. stock logo
abrdn plc Reduces Holdings in CONMED Co. (NYSE:CNMD)
abrdn plc reduced its holdings in shares of CONMED Co. (NYSE:CNMD - Free Report) by 18.0% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 135,937 shares of the company's stock after selling 29,841 shares duri
Conmed downgraded to Neutral from Overweight at JPMorgan
JP Morgan Downgrades CONMED (CNMD)
CONMED Co. stock logo
CONMED (NYSE:CNMD) Stock Price Expected to Rise, Stifel Nicolaus Analyst Says
Stifel Nicolaus boosted their price objective on shares of CONMED from $72.00 to $75.00 and gave the company a "buy" rating in a research report on Thursday.
CONMED Co. stock logo
Wells Fargo & Company Cuts CONMED (NYSE:CNMD) Price Target to $70.00
Wells Fargo & Company reduced their price target on shares of CONMED from $74.00 to $70.00 and set an "equal weight" rating for the company in a report on Thursday.
CONMED Co. stock logo
CONMED (NYSE:CNMD) Shares Gap Down After Analyst Downgrade
CONMED (NYSE:CNMD) Shares Gap Down Following Analyst Downgrade
CONMED Co. stock logo
CONMED (NYSE:CNMD) Price Target Lowered to $91.00 at Needham & Company LLC
Needham & Company LLC lowered their price objective on shares of CONMED from $97.00 to $91.00 and set a "buy" rating for the company in a research report on Thursday.
CONMED Co. stock logo
CONMED (NYSE:CNMD) Stock Rating Lowered by JPMorgan Chase & Co.
JPMorgan Chase & Co. cut shares of CONMED from an "overweight" rating to a "neutral" rating and dropped their target price for the stock from $85.00 to $70.00 in a report on Thursday.
Conmed Q4 Earnings Assessment
Conmed sees FY25 adjusted EPS $4.25-$4.40, consensus $4.74
Remove Ads
Get CONMED News Delivered to You Automatically

Sign up to receive the latest news and ratings for CNMD and its competitors with MarketBeat's FREE daily newsletter.

CNMD Media Mentions By Week

CNMD Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

CNMD
News Sentiment

1.20

0.78

Average
Medical
News Sentiment

CNMD News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

CNMD Articles
This Week

5

4

CNMD Articles
Average Week

Remove Ads
Get CONMED News Delivered to You Automatically

Sign up to receive the latest news and ratings for CNMD and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NYSE:CNMD) was last updated on 3/28/2025 by MarketBeat.com Staff
From Our Partners